Reference
Pennington B, et al. The Impact of Moving from EQ-5D-3L to -5L in NICE Technology Appraisals. PharmacoEconomics : 9 Aug 2018. Available from: URL: http://doi.org/10.1007/s40273-018-0701-y
Rights and permissions
About this article
Cite this article
Estimated QALY gain differs with use of EQ-5D-5L versus -3L. PharmacoEcon Outcomes News 810, 12 (2018). https://doi.org/10.1007/s40274-018-5203-9
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-018-5203-9